Peter Thilo Hasler

Peter Thilo Hasler

Director of Finance/CFO at B-A-L GERMANY AG

Net worth: 28 136 $ as of 2026-05-30

Finance
Health Technology

Profile

Mr. Peter Thilo Hasler is an Independent Director at Rapid Dose Therapeutics Corp., a Founder & Analyst at Sphene Capital GmbH and a Chief Financial Officer at B-A-L Germany AG.
He is on the Board of Directors at Rapid Dose Therapeutics Corp.
and DVFA e.V.
Mr. Hasler was previously employed as a Founder by sphaia advisory GmbH, a Co-Chairman by Viscardi Securities Wertpapierhandelsbank GmbH, an Analyst by Bayerische Hypo und Vereinsbank AG (Securities), and an Analyst by Viscardi AG (Research Firm).

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-07-06 370,214 ( 0.28% ) 28 136 $ 2026-05-30

Peter Thilo Hasler active positions

CompaniesPositionStart
RAPID DOSE THERAPEUTICS CORP. Director/Board Member 2020-08-12
B-A-L GERMANY AG Director of Finance/CFO -
Founder 2009-12-31
DVFA e.V.
Director/Board Member 2009-05-31

Former positions of Peter Thilo Hasler

CompaniesPositionEnd
Analyst-Equity 2006-06-20
sphaia advisory GmbH
Founder -
Analyst-Equity -
Chairman -
See the detail of Peter Thilo Hasler's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

4

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Finance

Finance

Finance

DVFA e.V.

Finance

Finance

Health Technology

sphaia advisory GmbH

  1. Stock Market
  2. Insiders
  3. Peter Thilo Hasler
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!